License and Agreements (Details) - USD ($)		1 Months Ended		3 Months Ended		9 Months Ended		12 Months Ended
	Aug. 12, 2020	Apr. 30, 2020	May 31, 2018	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019	Aug. 31, 2020	May 31, 2020	Jan. 31, 2020	Dec. 24, 2019	Aug. 31, 2019	Jun. 30, 2019	Jan. 31, 2019	Mar. 31, 2018
License and Agreements (Textual)
Assignment fee																$ 100,000
Milestone fee												$ 50,000
Common shares outstanding price percentage												1.00%
Amount of Common shares due payable								220,666
Fair value of common stock								1,132,000
Closing stock price												$ 5.13
Description of license and agreements						As of December 31, 2019, the Company had not paid the $50,000 or issued the shares and has included the $50,000 in accounts payable and the share amount due as a research and development expense payable. The Company paid the $50,000 and issued the shares in January 2020. As of the date of these condensed consolidated financial statements, the Company is in compliance with the patent license agreement as all required amounts have been paid in accordance with the agreement.
Research and development cost				$ 2,823,669	$ 2,563,528	$ 7,626,982	$ 5,554,046	$ 1,132,000
Manufacturing services		$ 3,089,000
Pre-marketing approvals	$ 25,000,000
Master Services [Member]
License and Agreements (Textual)
Assignment fee			$ 1,790,000												$ 3,607,000
Research and development cost				0	843,000	779,000	2,597,000
Irisys, LLC [Member]
License and Agreements (Textual)
Research and development cost				249,000	288,000	1,266,000	346,000
CoreRx [Member]
License and Agreements (Textual)
Assignment fee														$ 1,079,000
Research and development cost				384,000	177,000	626,000	295,000
Conform Clinical Development, Inc. [Member]
License and Agreements (Textual)
Assignment fee													$ 1,483,000
Research and development cost				709,000	$ 281,000	934,000	$ 281,000
Cinical Network Services Pty Ltd. ("CNS") [Member]
License and Agreements (Textual)
Research and development cost				99,000		218,000
Cinical Network Services Pty Ltd. ("CNS") [Member] | AUD [Member]
License and Agreements (Textual)
Assignment fee											$ 1,942,981
Research and development cost				139,000		323,000
Patheon Development Services [Member]
License and Agreements (Textual)
Description of license and agreements			The Company entered into a master services agreement and associated individual study contracts with ITR Canada, Inc. ("ITR") to provide initial contract pre-clinical research and development services for the Company's drug product candidates.
Nucleus Network Pty Ltd [Member]
License and Agreements (Textual)
Research and development cost				44,000		295,000
Nucleus Network Pty Ltd [Member] | AUD [Member]
License and Agreements (Textual)
Assignment fee										$ 1,392,805
Research and development cost				61,000		437,000
Q-Pharm Pty Ltd [Member]
License and Agreements (Textual)
Research and development cost				327,000		234,000
Q-Pharm Pty Ltd [Member] | AUD [Member]
License and Agreements (Textual)
Assignment fee									$ 704,600
Research and development cost				$ 327,000		$ 234,000